Comparison of Recovery Profile After TIVA Between Remimazolam With Flumazenil and Propofol
Status:
Not yet recruiting
Trial end date:
2022-08-10
Target enrollment:
Participant gender:
Summary
This prospective, randomized, single-blinded study is designed to compare the recovery
profile between propofol-based total intravenous anesthesia (TIVA) and remimazolam-based TIVA
in patients undergoing thyroidectomy. In the remimazolam group, its antagonist, flumazenil,
is administered at the end of surgery. We hypothesize that remimazolam-based TIVA antagonized
by flumazenil can significantly shorten the time from the end of anesthetic administration to
eye-opening compared to propofol-based TIVA.